Pharmigene, Inc. (TPEX:7595)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
10.00
+0.10 (1.01%)
Apr 29, 2026, 2:00 PM CST

Pharmigene Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
Apr '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2017
Market Capitalization
5057191,0458639431,087
Upgrade
Market Cap Growth
-29.33%-31.16%21.08%-8.53%-13.20%-
Upgrade
Enterprise Value
1,0461,1961,564667705913
Upgrade
Last Close Price
10.0014.2520.7019.8521.7025.00
Upgrade
PS Ratio
3.386.177.876.457.2910.72
Upgrade
PB Ratio
1.632.062.352.542.472.65
Upgrade
P/TBV Ratio
1.712.142.432.652.582.70
Upgrade
EV/Sales Ratio
7.0110.2611.794.985.459.01
Upgrade
Debt / Equity Ratio
1.991.771.290.030.040.05
Upgrade
Net Debt / Equity Ratio
1.751.310.92-0.55-0.59-0.67
Upgrade
Net Debt / EBITDA Ratio
-11.72-7.02-9.505.8815.3331.58
Upgrade
Net Debt / FCF Ratio
-6.41-4.18-0.555.487.0212.76
Upgrade
Asset Turnover
0.150.110.190.330.300.33
Upgrade
Inventory Turnover
2.471.853.223.774.614.13
Upgrade
Quick Ratio
1.623.285.095.8510.3213.03
Upgrade
Current Ratio
2.464.776.926.7511.5214.16
Upgrade
Return on Equity (ROE)
-21.55%-20.89%-18.54%-11.83%-5.92%-4.15%
Upgrade
Return on Assets (ROA)
-4.25%-5.20%-5.17%-6.92%-3.27%-2.79%
Upgrade
Return on Capital Employed (ROCE)
-7.60%-9.00%-5.90%-12.80%-5.80%-3.30%
Upgrade
Earnings Yield
-14.96%-11.52%-6.95%-4.95%-2.48%-1.03%
Upgrade
FCF Yield
-16.74%-15.22%-71.11%-3.94%-3.39%-1.99%
Upgrade
Buyback Yield / Dilution
-3.03%-10.96%-4.63%--28.48%-53.99%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.